Loading profile…

Loading activity…

World & Business

Home
Technology
Gaming
Entertainment
World & Business
Science
Sports
AI

Home
Technology
Gaming
Entertainment
World & Business
Science
Sports
AI

OncoDaily Biotech (@oncodailybio) · Digg

OncoDaily Biotech

@oncodailybio

following
followers

Featured in

World & Business

Imdelltra-Imfinzi combo shows 58% lower death risk than Imfinzi alone in lung cancer trial

CNBC reports median survival was 21.1 months with the combination, versus 12.7 months with Imfinzi alone.

6601234567890123456789

7 Sources, 19d ago, updated 19d ago

Connections

@OncoDailyBio